Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 6/20 | 0.79 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.79 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.79 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.79 |
| ▸ | MAPT | P10636 | 4/20 | 0.79 |
| ▸ | HPGD | P15428 | 4/20 | 0.79 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.79 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.79 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.79 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.79 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.79 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.79 |
| ▸ | THRB | P10828 | 1/20 | 0.79 |
| ▸ | MAOA | P21397 | 2/20 | 0.77 |
| ▸ | MAOB | P27338 | 2/20 | 0.77 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.77 |
| ▸ | ABCG2 | Q9UNQ0 | 5/20 | 0.77 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.77 |
| ▸ | NFKB1 | P19838 | 4/20 | 0.73 |
| ▸ | NFKB2 | Q00653 | 3/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25194592 | 1.00 | MEN1 (0.79) | MEN1KMT2ACYP3A4TDP1MAPT | |
| SCHEMBL14027262 | 1.00 | MEN1 (0.79) | MEN1KMT2ACYP3A4TDP1MAPT | |
| Methyl Alcohol SCHEMBL25196695 | 0.97 | ABCG2 (0.78) | MEN1KMT2ACYP3A4TDP1MAPT | |
| SCHEMBL28093997 | 0.95 | MEN1 (0.82) | MEN1KMT2ACYP3A4TDP1MAPT | |
| SCHEMBL25195193 | 0.95 | MEN1 (0.82) | MEN1KMT2ACYP3A4TDP1MAPT | |
| 2',4'-Dihydroxychalcone SCHEMBL25200440 | 0.89 | MAPT (1.00) | MEN1KMT2ACYP3A4TDP1MAPT | |
| 2',4'-Dihydroxychalcone SCHEMBL127341 | 0.89 | MAPT (1.00) | MEN1KMT2ACYP3A4TDP1MAPT | |
| 2',4'-Dihydroxychalcone SCHEMBL1411695 | 0.89 | MAPT (1.00) | MEN1KMT2ACYP3A4TDP1MAPT | |
| SCHEMBL9702245 | 0.88 | CYP3A4 (0.71) | MEN1KMT2ACYP3A4TDP1MAPT | |
| SCHEMBL9702240 | 0.88 | CYP3A4 (0.71) | MEN1KMT2ACYP3A4TDP1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260014100-A1 | Compositions and Methods for Treating Bleeding and Bleeding Disorders | YEWSAVIN INC (US) | 2026-01-15 | — | — | US | disclosed |
| US-12343317-B2 | Compositions and methods for treating bleeding and bleeding disorders | YewSavin, Inc. (US) | 2025-07-01 | — | — | US | disclosed |
| WO-2024233598-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | YewSavin, Inc. (US) | 2024-11-14 | — | — | WO | disclosed |
| EP-4429763-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | Yewsavin, Inc. (US) | 2024-09-18 | — | — | EP | disclosed |
| WO-2023086388-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | YewSavin, Inc. (US) | 2023-05-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260014100-A1 | Compositions and Methods for Treating Bleeding and Bleeding Disorders | SERPINC1, F2, F13B | MEN1 3367/4885KMT2A 2792/4885CYP3A4 928/4885 |
| US-12343317-B2 | Compositions and methods for treating bleeding and bleeding disorders | SERPINC1, SERPINE1, SERPINH1 | MEN1 2457/4885KMT2A 3188/4885CYP3A4 1589/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.